Prelude Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,802
Closed -$400K 1311
2025
Q2
$400K Sell
5,802
-11,412
-66% -$776K 0.04% 504
2025
Q1
$1.2M Buy
+17,214
New +$1.42M 0.09% 264
2024
Q4
Sell
-5,390
Closed -$583K 1443
2024
Q3
$642K Buy
5,390
+3,288
+156% +$439K 0.04% 530
2024
Q2
$300K Buy
+2,102
New +$279K 0.02% 793
2024
Q1
Sell
-11,247
Closed -$1.16M 1470
2023
Q4
$1.16M Buy
11,247
+5,247
+87% +$519K 0.08% 266
2023
Q3
$546K Sell
6,000
-8,690
-59% -$766K 0.04% 447
2023
Q2
$1.19M Sell
14,690
-5,510
-27% -$450K 0.08% 276
2023
Q1
$1.61M Buy
20,200
+1,054
+6% +$74.7K 0.1% 237
2022
Q4
$1.3M Sell
19,146
-5,088
-21% -$298K 0.07% 305
2022
Q3
$1.21M Buy
+24,234
New +$1.3M 0.04% 365
2022
Q1
Sell
-15,808
Closed -$885K 2102
2021
Q4
$885K Buy
15,808
+1,268
+9% +$68.7K 0.02% 677
2021
Q3
$698K Buy
14,540
+3,058
+27% +$148K 0.02% 724
2021
Q2
$481K Buy
11,482
+68
+0.6% +$2.64K 0.01% 984
2021
Q1
$385K Buy
11,414
+2,216
+24% +$78.9K 0.01% 1022
2020
Q4
$321K Buy
+9,198
New +$318K 0.01% 887
2019
Q4
Sell
-17,736
Closed -$458K 2149
2019
Q3
$458K Buy
+17,736
New +$448K 0.02% 541
2019
Q2
Sell
-22,660
Closed -$593K 2008
2019
Q1
$593K Buy
+22,660
New +$557K 0.03% 455
2016
Q4
Sell
-3,400
Closed -$71K 1713
2016
Q3
$71K Buy
+3,400
New +$84.3K 0.01% 934
2015
Q2
Sell
-1,800
Closed -$48K 1944
2015
Q1
$48K Hold
1,800
0.01% 1302
2014
Q4
$38K Sell
1,800
-24,300
-93% -$543K 0.01% 1428
2014
Q3
$624K Hold
26,100
0.09% 289
2014
Q2
$601K Buy
+26,100
New +$576K 0.08% 319
2014
Q1
Sell
-32,300
Closed -$591K 2038
2013
Q4
$591K Hold
32,300
0.1% 294
2013
Q3
$548K Sell
32,300
-24,440
-43% -$411K 0.09% 271
2013
Q2
$884K Buy
+56,740
New +$944K 0.19% 126

Other funds holding NVO